[APLS] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -7.10%
YoY- -27.96%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 172,325 44,846 14,381 0 0 0 0 -
PBT -66,253 -177,496 -137,727 -183,659 -168,822 -50,574 -21,736 20.39%
Tax 170 282 1,208 5,719 3,933 340 267 -7.24%
NP -66,423 -177,778 -138,935 -183,659 -168,822 -50,574 -21,736 20.44%
Tax Rate - - - - - - - -
Total Cost 238,748 222,624 153,316 183,659 168,822 50,574 21,736 49.03%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -38.55 -396.42 -966.10 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.54 -1.56 -1.42 -2.32 -2.29 -0.87 -0.43 3.86%
EPS Diluted -0.54 -1.56 -1.42 -2.32 -2.29 -0.87 -0.43 3.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.